对腹部有敌意的患者进行单孔经膀胱机器人根治性前列腺切除术。
Single-Port Transvesical Robotic Radical Prostatectomy in a Patient with Hostile Abdo-men.
发表日期:2024 Aug 12
作者:
Sij Hemal, Sina Sobhani
来源:
DIABETES & METABOLISM
摘要:
使用达芬奇单端口 (SP) 机器人进行机器人根治性前列腺切除术可以提供可比的功能和肿瘤学结果,并在围手术期发病率方面具有潜在优势,特别是对于既往有丰富腹部手术史的患者 (1, 2)。病例是一名 74 岁男性,有糖尿病、心脏搭桥手术、高血压和高脂血症病史,PSA 为 7.2。他的 MRI 显示左心尖和中腺周围区有 PIRADS-5 病变,在 MRI 引导融合活检后被诊断为不利的中危前列腺癌。他的体重指数为 31,过去的手术史与因枪伤而进行的两次剖腹探查术以及随后逆转的结肠造口术有关。机器人根治性前列腺切除术的标准化步骤是使用作者 SH (3, 4) 执行的 SP 机器人平台进行的。总手术时间和估计失血量分别为 210 分钟和 150 mL。患者于术后第一天出院,最终病理显示前列腺腺癌,格里森评分4±3=7,pT2NxR0,手术切缘阴性。患者在手术后 4 周即可恢复正常,三个月后 PSA 仍检测不到。使用单孔平台的经膀胱根治性前列腺切除术可提供可接受的肿瘤和功能结果,并且由于肠梗阻和腹膜刺激的风险降低,恢复更快。鉴于腹腔没有受到侵犯,肠道或血管损伤的风险就会降低,特别是对于腹部有敌意的患者。Copyright®由国际巴西泌尿学杂志提供。
Robotic Radical Prostatectomy using the Da-Vinci Single-Port (SP) robot can provide comparable functional and oncological outcomes with potential advantages pertaining to peri-operative morbidity, especially in patients with an extensive history of prior abdominal surgeries (1, 2).Our case is a 74-year-old male with a history of diabetes, cardiac bypass, hypertension, and hyperlipidemia, presenting with a PSA of 7.2. His MRI showed a PIRADS-5 lesion in the left apex and mid-gland peripheral zone, and he was diagnosed with unfavorable intermediate-risk prostate cancer after MRI guided fusion biopsy. His BMI was 31, and past surgical history was pertinent for two exploratory laparotomies due to gunshot wounds and a colostomy creation followed by reversal. The standardized steps of robotic radical prostatectomy were carried out using SP robotic platform performed by author SH (3, 4).Total operative time and estimated blood loss were 210 minutes and 150mL respectively. The patient was discharged on postoperative day one and final pathology showed adenocarcinoma of the prostate Gleason score 4+3=7, pT2NxR0 and negative surgical margins. The patient was continent four weeks after surgery and the PSA continues to be undetectable after three months.Transvesical Radical prostatectomy using the single port platform provides acceptable oncological and functional outcomes and quicker recovery given decreased risk of ileus and peritoneal irritation. Given that the abdominal cavity is not violated, the risk of bowel or vascular injury is mitigated, especially in patients with a hostile abdomen.Copyright® by the International Brazilian Journal of Urology.